Home > Insider Trading > Filing (0001209191-20-035104)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1662774	Cortexyme Inc.	CRTX	Biological Products, (No Disgnostic Substances) (2836)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1770790	David Lamond	C/O Cortexyme, Inc. 269 East Grand Ave. South San Francisco CA 94080		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2020-06-04	13,609	$42.13	1,711,593	No	4	P	Indirect	By Blue Devil Trust dated 12/03/2010
Common Stock	Acquisiton	2020-06-04	10,642	$43.32	1,722,235	No	4	P	Indirect	By Blue Devil Trust dated 12/03/2010
Common Stock	Acquisiton	2020-06-04	24,874	$43.88	1,747,109	No	4	P	Indirect	By Blue Devil Trust dated 12/03/2010

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By Blue Devil Trust dated 12/03/2010
No	4	P	Indirect	By Blue Devil Trust dated 12/03/2010
No	4	P	Indirect	By Blue Devil Trust dated 12/03/2010

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	301,829	Direct

Footnotes

The range of prices for the shares of Common Stock is from $41.58 to $42.55. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities purchased at each separate price.
Mr. Lamond is the trustee of Blue Devil Trust dated 12/03/2010 (the "Trust") and holds sole voting and dispositive power with respect to the shares held of record by the Trust.
The range of prices for the shares of Common Stock is from $42.61 to $43.60. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities purchased at each separate price.
The range of prices for the shares of Common Stock is from $43.61 to $44.10. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities purchased at each separate price.